| Members |
targetComponentId |
| Heparin sodium in 0.9% sodium chloride 1000iu/500mL infusion |
Product containing only heparin in parenteral dose form (medicinal product form) |
| Hepatectomy |
Excision of liver (procedure) |
| Hepatic colic |
Biliary colic |
| Hepatitis |
Inflammatory disease of liver |
| Hepatitis B group virus |
Genus Orthohepadnavirus (organism) |
| humant immunglobulin mot hepatit B 1000 IE, pulver till injektionsvätska, flaska |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| humant immunglobulin mot hepatit B 200 IE, pulver till injektionsvätska, flaska |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| humant immunglobulin mot hepatit B 500 IE, pulver till injektionsvätska, flaska |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| Hepatitis B screening test |
Hepatitis B screening |
| Hepatitis B screening test |
Hepatitis B screening |
| screeningtest avseende hepatit B |
Hepatitis B screening |
| humant immunglobulin mot hepatit B 217 enheter, injektionsvätska, lösning, flaska |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| humant immunglobulin mot hepatit B 312 enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
| humant immunglobulin mot hepatit B 312 enheter/ml, injektionsvätska, lösning, flaska 5 ml |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
| toxoplasmahepatit |
Hepatitis caused by Toxoplasma gondii |
| non-A-non-B-hepatit |
Viral hepatitis |
| Hepatitis panel |
Hepatitis panel measurement |
| Hepatocerebral encephalopathy |
Hepatic encephalopathy |
| Herbaspirillum rubrisualbicans |
Herbaspirillum rubrisubalbicans (organism) |
| Hereditary disease |
Hereditary disease |
| ärftligt syndrom med endoteliopati, retinopati, nefropati och stroke |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| ärftlig methemoglobinemi, enzymatisk typ |
Autosomal recessive congenital methemoglobinemia (disorder) |
| ärftlig icke-sfärocytär hemolytisk anemi orsakad av aldolas A-brist |
Glycogen storage disease due to aldolase A deficiency (disorder) |
| ärftlig icke-sfärocytisk hemolytisk anemi orsakad av brist på NADH-methemoglobin-reduktas |
Autosomal recessive congenital methemoglobinemia (disorder) |
| Hereditary progressive muscular dystrophy |
Muscular dystrophy |
| ärftlig sensorisk och motorisk neuropati, typ V |
Hereditary motor and sensory neuropathy type 5 (disorder) |
| ärftligt lokaliserat äggstockscancersyndrom |
Hereditary breast and ovarian cancer syndrome (disorder) |
| Hereditary thrombocytopenia NEC |
Hereditary thrombocytopenic disorder (disorder) |
| ärftlig vaskulär retinopati |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| Hermansky-Pudlack syndrome |
Hermansky-Pudlak syndrome |
| hermafroditism |
Ovotesticular disorder of sex development |
| Hermaphroditism |
Ovotesticular disorder of sex development |
| heroin, icke läkemedel |
Diamorphine (substance) |
| Herpailurus yaguarondi |
Puma yagouaroundi (organism) |
| Herpes simplex with other specified complications |
Herpes simplex with complication |
| Herpes simplex with unspecified complications |
Herpes simplex with complication |
| herpes zoster med oftalmisk komplikation |
Herpes zoster ophthalmicus |
| Herpes zoster with other complications |
Herpes zoster with complication |
| Herpes zoster with other nervous system complications |
Herpes zoster with nervous system complication |
| Herpes zoster with other ophthalmic complication |
Herpes zoster ophthalmicus |
| sill eller strömming, livsmedel |
Herring (substance) |
| Hetastarch 6% |
Hetastarch 60 mg/mL solution for injection |
| hetastarch 6 %, infusionsvätska, lösning, flaska |
Hetastarch 60 mg/mL solution for injection |
| Hetastarch 6g liquid |
Hetastarch 60 mg/mL solution for injection |
| hydroxietylstärkelseallergi |
Non-allergic hypersensitivity to hetastarch (finding) |
| Heteropagus |
Asymmetrical conjoined twins (disorder) |
| extrakt specifikt för hexahydroftalsyraanhydrid |
Hexahydrophthalic anhydride (substance) |
| extrakt specifikt för hexametylendiisocyanat |
Hexamethylene diisocyanate (substance) |
| hexastarch 6 %, infusionsvätska, lösning, flaska |
Product containing precisely hexastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Hexosyltransferase |
Hexosyltransferase |
| hickmankateter |
Central venous catheter |
| injektion i hickmankateter |
Central venous catheter injection |
| spets på hickmankateter |
Central venous catheter tip |
| High risk non proliferative diabetic retinopathy |
Severe nonproliferative retinopathy due to diabetes mellitus (disorder) |
| High risk of |
High risk of |
| Hind brain contusion with open intracranial wound, unspecified state of consciousness |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hind brain contusion with open intracranial wound, with concussion, unspecified |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hind brain contusion with open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of hindbrain with open intracranial wound (disorder) |
| Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of hip (procedure) |
| Hip enthesopathy NOS |
Enthesopathy of hip region |
| Hip enthesopathy, unspecified |
Enthesopathy of hip region |
| poäng för höftfrakturrisk enligt WHO:s verktyg för skattning av frakturrisk, FRAX |
Hip fracture probability score using fracture risk assessment tool (observable entity) |
| somatisk dysfunktion i höft |
Somatic dysfunction of hip region (finding) |
| mätning av hippuranclearance i njurar |
Measurement of renal clearance |
| hippuranclearance i njurar |
Renal clearance |
| renografi med hippuran |
Renal isotope studies |
| renografi med hippuran och effektivt renalt plasmaflöde (ERPF) |
Renal isotope studies |
| Hirundo fulva |
Petrochelidon fulva (organism) |
| Hirundo pyrrhonota |
Cliff swallow |
| histaminfosfat 275 mikrogram/ml, injektionsvätska, lösning, ampull |
Histamine only product in parenteral dose form |
| histiocytär proliferation |
Histiocytic proliferation (morphologic abnormality) |
| Histiocytoid hemangioma |
Epithelioid hemangioma |
| urotelial cancer, histologisk grad enligt WHO-ISUP |
Histologic grade of urothelial carcinoma by World Health Organization technique |
| histologisk grad |
Histologic grade (property) |
| histologisk typ |
Histologic type (property) (qualifier value) |
| anamnes och fysisk undersökning för diagnostik |
History AND physical examination |
| anamnes: allergi mot ACE-hämmare |
H/O: angiotensin converting enzyme inhibitor pseudoallergy |
| anamnes: allergi mot smärtstillande läkemedel |
Allergy to drug |
| anamnes: allergi mot anestesimedel |
Allergy to drug |
| anamnes: kattallergi |
Allergy to Felis catus protein (finding) |
| anamnes: läkemedelsberoende |
History of substance dependency (situation) |
| familjeanamnes: funktionshinder hos barn till patient |
Child of subject has disability (situation) |
| anamnes: malign tumör i kolon och/eller rektum |
History of malignant neoplasm of cecum and/or colon and/or rectum |
| anamnes: tobaksanvändning |
Ex-tobacco user |
| Hodgkins granulom [obs] |
Hodgkin granuloma |
| Hodgkins lymfom, kategori |
Hodgkin lymphoma |
| Hodgkins lymfom |
Hodgkin lymphoma |
| Hodgkins sarkom [obs] |
Hodgkin sarcoma (morphologic abnormality) |
| Hodgkins sjukdom, extranodal och/eller organlokaliserad |
Hodgkin's disease (clinical) |
| Hodgkins sjukdom i lymfknutor i axill och/eller arm |
Hodgkin disease of lymph nodes of upper limb (disorder) |
| Hodgkins sjukdom i lymfknutor i inguinalregion och/eller nedre extremitet |
Hodgkin disease of lymph nodes of lower limb (disorder) |
| Hodgkins sjukdom, lymfocytfattig, extranodal och/eller organlokaliserad |
Hodgkin's disease, lymphocytic depletion (clinical) |
| Hodgkins sjukdom med lymfocytfattiga lymfknutor i axill och/eller arm |
Hodgkin disease, lymphocytic depletion of lymph nodes of upper limb (disorder) |
| Hodgkins sjukdom med lymfocytfattiga lymfknutor i axill och arm |
Hodgkin disease, lymphocytic depletion of lymph nodes of upper limb (disorder) |
| Hodgkins sjukdom, lymfocytfattiga lymfknutor i huvud, ansikte och hals |
Hodgkin lymphoma, lymphocyte depletion of lymph nodes of head and neck (disorder) |
| Hodgkins sjukdom med lymfocytfattiga lymfknutor i inguinalregion och/eller nedre extremitet |
Hodgkin disease, lymphocytic depletion of lymph nodes of lower limb (disorder) |
| Hodgkins sjukdom med lymfocytfattiga lymfknutor i inguinalregion och ben |
Hodgkin disease, lymphocytic depletion of lymph nodes of lower limb (disorder) |
| Hodgkin's disease, lymphocytic predominance |
Hodgkin lymphoma, lymphocyte-rich |
| Hodgkin's disease, lymphocytic predominance, diffuse |
Hodgkin lymphoma, lymphocyte-rich |
FHIR